3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review

3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review

Submitted by admin on July 1, 2011 - 9:44am
Source: 
Motley Fool
News Tags: 
FDA
Bristol-Myers Squibb
AstraZeneca
Pfizer
Incyte
Novartis
ruxolitinib
Apixaban
Dapagliflozin
Headline: 
3 Biotech Drugs With Promising Phase III Data, Moving Into FDA Review

Do Not Allow Advertisers to Use My Personal information